{"id":"sodium-hyaluronate-0-15","safety":{"commonSideEffects":[{"rate":null,"effect":"Mild ocular irritation"},{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Foreign body sensation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sodium hyaluronate is a naturally occurring polysaccharide that acts as a humectant and lubricant on the eye surface. It binds water molecules and forms a protective layer over the cornea and conjunctiva, reducing friction and providing sustained hydration. This mechanism makes it effective for treating dry eye and protecting the ocular surface during and after ophthalmic procedures.","oneSentence":"Sodium hyaluronate is a viscoelastic substance that lubricates and protects the ocular surface by mimicking natural tear film.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:40.528Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome"},{"name":"Ocular surface protection during ophthalmic surgery"},{"name":"Post-operative ocular surface care"}]},"trialDetails":[{"nctId":"NCT07451184","phase":"PHASE4","title":"Comparison of Ocular Lubricants in People With Symptoms of Dry Eye","status":"RECRUITING","sponsor":"University of Waterloo","startDate":"2026-02-23","conditions":"Dry Eye Symptoms","enrollment":100},{"nctId":"NCT04702776","phase":"PHASE4","title":"Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2021-12-09","conditions":"Dry Eye","enrollment":182},{"nctId":"NCT06163989","phase":"NA","title":"Protecting the Eyes of Gamers With Lubricating Eyedrops","status":"RECRUITING","sponsor":"Aston University","startDate":"2024-09-01","conditions":"Dry Eye Syndromes, Computer Vision Syndrome","enrollment":28},{"nctId":"NCT07089511","phase":"NA","title":"Cord Blood Platelet Poor Plasma Eye Drops","status":"RECRUITING","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2025-03-11","conditions":"Dry Eye","enrollment":100},{"nctId":"NCT06936462","phase":"NA","title":"Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation","status":"COMPLETED","sponsor":"Hallym University Kangnam Sacred Heart Hospital","startDate":"2020-01-20","conditions":"Dry Eye Syndrome (DES)","enrollment":50},{"nctId":"NCT06370585","phase":"PHASE1","title":"Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2024-05-16","conditions":"Dry Eye Disease, Ocular Surface Disease","enrollment":36},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT05931861","phase":"NA","title":"Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2023-08-15","conditions":"Dry Eye","enrollment":34},{"nctId":"NCT05290727","phase":"NA","title":"Efficacy of \"Aquoral Lipo\" Artificial Tears in Contact Lens Wearers With Discomfort","status":"COMPLETED","sponsor":"Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA","startDate":"2022-03-01","conditions":"Contact Lens Complication","enrollment":41},{"nctId":"NCT06189456","phase":"NA","title":"Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%","status":"UNKNOWN","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2023-06-21","conditions":"Dry Eye Syndrome (DES)","enrollment":100},{"nctId":"NCT06517667","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-11-01","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT06478134","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-07-01","conditions":"Dry Eye","enrollment":124},{"nctId":"NCT02975102","phase":"NA","title":"A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye","status":"COMPLETED","sponsor":"Laboratoire Chauvin","startDate":"2017-03-01","conditions":"Dry Eye","enrollment":87},{"nctId":"NCT04704518","phase":"PHASE4","title":"Phase IV Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy (PRK)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2022-09-03","conditions":"Photorefractive Keratectomy, Corneal De-epithelialization","enrollment":88},{"nctId":"NCT06317922","phase":"NA","title":"Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF Injections","status":"RECRUITING","sponsor":"Francesco Bandello","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":60},{"nctId":"NCT05159284","phase":"PHASE4","title":"Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction","status":"RECRUITING","sponsor":"Laboratorios Thea, Spain","startDate":"2021-11-09","conditions":"Dry Eye, Meibomian Gland Dysfunction","enrollment":54},{"nctId":"NCT06209879","phase":"PHASE4","title":"Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT06119386","phase":"NA","title":"Quantum Molecular Resonance Electrotherapy in Severe Dry Eye Disease","status":"COMPLETED","sponsor":"Centro Oculistico Borroni","startDate":"2022-11-03","conditions":"Dry Eye","enrollment":81},{"nctId":"NCT04465071","phase":"NA","title":"Lubricating Eye Drops After Routine Cataract Surgery","status":"COMPLETED","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2020-02-24","conditions":"Dry Eye, Cataract","enrollment":79},{"nctId":"NCT05618730","phase":"PHASE1","title":"Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B","status":"UNKNOWN","sponsor":"Eximore Ltd.","startDate":"2022-09-29","conditions":"Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation","enrollment":20},{"nctId":"NCT05536661","phase":"NA","title":"Impact of Tear Substitute Use on Dry Eye in Gamers.","status":"COMPLETED","sponsor":"Laboratorios Thea, Spain","startDate":"2019-07-04","conditions":"Evaporative Dry Eye","enrollment":56},{"nctId":"NCT04127851","phase":"PHASE4","title":"Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients","status":"COMPLETED","sponsor":"Taejoon Pharmaceutical Co., Ltd.","startDate":"2019-11-12","conditions":"Dry Eye, Dry Eye Syndromes","enrollment":438},{"nctId":"NCT03640351","phase":"NA","title":"Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2017-08-15","conditions":"Dry Eye, Cataract Surgery","enrollment":150},{"nctId":"NCT04131335","phase":"NA","title":"Use of Prophylactic Lubricating Drops After Cataract Surgery","status":"UNKNOWN","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2019-10-14","conditions":"Dry Eye, Cataract Surgery, Patient Related Outcome Measures","enrollment":168},{"nctId":"NCT03888183","phase":"PHASE4","title":"Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-04-17","conditions":"Dry Eye","enrollment":334},{"nctId":"NCT04000789","phase":"NA","title":"The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)","status":"UNKNOWN","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2019-07","conditions":"Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy New Vessels on Disc, Dry Eye Syndromes","enrollment":96},{"nctId":"NCT02332109","phase":"","title":"ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy","status":"COMPLETED","sponsor":"TRB Chemedica AG","startDate":"2015-09","conditions":"Fuchs' Endothelial Dystrophy, Corneal Edema","enrollment":29},{"nctId":"NCT01791426","phase":"NA","title":"A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye","status":"WITHDRAWN","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-05","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT00760045","phase":"PHASE2","title":"Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-08","conditions":"Dry Eye Disease","enrollment":40},{"nctId":"NCT00493662","phase":"PHASE4","title":"Cross-Over Evaluation of Two Lubricating Eye Drops","status":"COMPLETED","sponsor":"Innovative Medical","startDate":"","conditions":"Dry Eye","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hyabak® PF"],"phase":"marketed","status":"active","brandName":"Sodium hyaluronate 0.15%","genericName":"Sodium hyaluronate 0.15%","companyName":"Laboratorios Sophia S.A de C.V.","companyId":"laboratorios-sophia-s-a-de-c-v","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium hyaluronate is a viscoelastic substance that lubricates and protects the ocular surface by mimicking natural tear film. Used for Dry eye syndrome, Ocular surface protection during ophthalmic surgery, Post-operative ocular surface care.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}